New Products/
New Indications

FDA Approved
Oncology
Aliqopa™ (copanlisib)
Besponsa® (inotuzumab ozogamicin)
IDHIFA® (enasidenib)
Imbruvica® (ibrutinib) - new indication
Lynparza™ (olaparib) - new formulation
Mylotarg™ (gemtuzumab ozogamicin)
Nerlynx™ (neratinib)
Pharmaceuticals
Benlysta® (belimumab) - Additional formulations
Radicava™ (edaravone)
Triptodur™ (triptorelin)


At ASD Healthcare, we continuously expand our product lines to ensure access to the products your patients need. We’re highlighting our newly added products here to make reviewing fast and easy. In addition, we're providing new product indications as they are approved by the FDA. To verify a product is appropriate for your facility to order, simply contact your sales representative. We’re always here to help.

To see the most up-to-date list of new products available from ASD Healthcare, simply check back each week!
 
Access additional
Product Resources